![Peter Kiener, D.Phil, Chief Scientific Officer (CSO)](http://www.globenewswire.com/fr/Attachment/LogoDisplay/315059?filename=315059.jpg&size=2)
Sucampo Solidifies Leadership Team With Additions of CSO and Heads of Business Development, Regulatory Affairs
23 oct. 2014 16h02 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced three executive appointments that expand and...